Use of ctDNA in early breast cancer: analytical validity and clinical potential
Abstract Circulating free tumor DNA (ctDNA) analysis is gaining popularity in precision oncology, particularly in metastatic breast cancer, as it provides non-invasive, real-time tumor information to complement tissue biopsies, allowing for tailored treatment strategies and improved patient selectio...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Portfolio
2024-06-01
|
| סדרה: | npj Breast Cancer |
| גישה מקוונת: | https://doi.org/10.1038/s41523-024-00653-3 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|